Viewing Study NCT07201558


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2025-12-25 @ 10:26 PM
Study NCT ID: NCT07201558
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-09-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-12-02
Start Date Type: ACTUAL
Primary Completion Date: 2028-06-27
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-06-27
Completion Date Type: ESTIMATED
First Submit Date: 2025-09-30
First Submit QC Date: None
Study First Post Date: 2025-10-01
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-11
Last Update Post Date: 2025-12-18
Last Update Post Date Type: ESTIMATED